A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)

ClinicalTrials.gov ID: NCT07759245

Public ClinicalTrials.gov record NCT07759245. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Oct 16, 2026, 9:34 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Multicenter, Randomized, Double-Blind, 52-week Study to Investigate the Efficacy and Safety of Brenipatide Compared With Placebo for the Treatment of Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The main purpose of this study is to assess if different dose levels of Brenipatide are safe and work the way they are intended to work in participants with moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD), when compared with placebo. The study will last approximately one year.

Study identification

NCT ID: NCT07759245
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 2
Lead sponsor: Eli Lilly and Company; Industry
Enrollment: 606 participants

Conditions and interventions

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

Drug

Eligibility (public fields only)

Age range: 40 Years to 75 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Aug 7, 2026 (Actual)
Primary completion: May 2028 (Estimated)
Completion: Nov 2028 (Estimated)
Last update posted: Oct 8, 2026

2026 – 2028

United States locations

U.S. sites: 18
U.S. states: 12
U.S. cities: 18

Facility	City	State	ZIP	Site status
University of Alabama at Birmingham	Birmingham	Alabama	35233	Recruiting
NewportNativeMD, Inc.	Newport Beach	California	92663	Recruiting
Institute of HealthCare Assessment d/b/a Apex Clinical Research	San Diego	California	92120	Recruiting
National Jewish Health Medical Center	Denver	Colorado	80206	Not yet recruiting
Millennium Medical Research - Miami	Miami	Florida	33126	Recruiting
Deluxe Health Center	Miami Lakes	Florida	33014	Recruiting
Florida Institute For Clinical Research, LLC	Orlando	Florida	32825	Recruiting
Axis Clinical Trials - Westchester	Westchester	Illinois	60154	Recruiting
Indiana University Health University Hospital	Indianapolis	Indiana	46202	Recruiting
IU Health Ball Memorial Hospital, Inc.	Muncie	Indiana	47303	Recruiting
Brigham and Women's Hospital	Boston	Massachusetts	02115	Not yet recruiting
Revive Research Institute, Inc.	Southfield	Michigan	48075	Recruiting
Headlands Research-Twin Cities	Maplewood	Minnesota	55109	Recruiting
Clinical Research Associates of Central PA	DuBois	Pennsylvania	15801	Recruiting
Premier Pulmonary Critical Care and Sleep	Denison	Texas	75020	Not yet recruiting
Baylor College of Medicine Medical Center	Houston	Texas	77030	Not yet recruiting
Prime Clinical Research - Lewisville	Lewisville	Texas	75067	Recruiting
Paramount Clinical Research - Data Point Clinical Research	Kirkland	Washington	98034	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 109 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT07759245, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Oct 8, 2026 · Synced Oct 16, 2026

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT07759245 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →